OpenPrescribing Newsletter: January 2018
- Posted:
- Written by:
-
- Emma-Jane Greig
- Categories:
This post is part of a series: OpenPrescribing Newsletters
- OpenPrescribing Newsletter: Autumn 2026
- OpenPrescribing Newsletter: Spring 2026
- OpenPrescribing Newsletter: October 2025
- OpenPrescribing Newsletter: Autumn 2025
- OpenPrescribing Newsletter: August 2025
- OpenPrescribing Newsletter: Autumn 2024
- OpenPrescribing Newsletter: Summer 2024
- OpenPrescribing Newsletter: Spring 2024
- OpenPrescribing Newsletter: Winter 2024
- OpenPrescribing Newsletter: Autumn 2023
- OpenPrescribing Newsletter: June 2022
- OpenPrescribing Newsletter: December 2021
- OpenPrescribing Newsletter: March 2021
- OpenPrescribing Newsletter: November 2020
- OpenPrescribing Newsletter: July 2020
- OpenPrescribing Newsletter: June 2020
- OpenPrescribing Newsletter: May 2020
- OpenPrescribing Newsletter: November 2019
- OpenPrescribing Newsletter: October 2019
- OpenPrescribing Newsletter: September 2019
- OpenPrescribing Newsletter: Summer 2019
- OpenPrescribing Newsletter: June 2019
- OpenPrescribing Newsletter: May 2019
- OpenPrescribing Newsletter: February 2019
- OpenPrescribing Newsletter: December 2018
- OpenPrescribing Newsletter: October 2018
- OpenPrescribing Newsletter: July 2018
- OpenPrescribing Newsletter: June 2018
- OpenPrescribing Newsletter: May 2018
- OpenPrescribing Newsletter: April 2018
- OpenPrescribing Newsletter: March 2018
- OpenPrescribing Newsletter: February 2018
- OpenPrescribing Newsletter: January 2018
- OpenPrescribing Newsletter: December 2017
- OpenPrescribing Newsletter: November 2017
- OpenPrescribing Newsletter: October 2017
New Year - same Price Concessions issues…
Everyone at the Bennett Institute wishes you a very Happy New Year!
Unfortunately, the NHS is still having the same problems in sourcing generics. The PSNC announced the latest list of price concessions for December 2017, slightly smaller than November’s, with 86 lines. However, we still estimated a monthly impact for the NHS in December of £27 million, bringing the total excess cost for the nine months to December to £285 million:
As always, we used the latest available month’s prescribing data (in this case October 2017) to estimate the impact for November and December, and updated our calculations for October as an actual cost.
Read more here, and look out for an update when January’s list is released.
Trends and variation in gluten-free food prescribing
Our analysis and the OpenPrescribing site show that areas where gluten free prescribing is restricted do have much lower rates of gluten-free prescribing, if you look at the map below in comparison with the prescribing policy map.
We’ve also determined that there is a lot of variation amongst practices, with some practices prescribing none at all. What is clear is that there is a recent trend over the last two years towards a drop in overall prescribing.
There are potential clinical benefits to doctors being able to prescribe gluten-free foods, and there are potential cost saving advantages to restricting their prescribing. However the current situation is a strange and rapidly changing middle ground, where availability is different according to where you live.
Our preprint paper explores this issue further, including investigating some of the factors associated with volume of gluten-free prescribing, such as practice list size or deprivation score. You can also explore the volume of gluten-free prescribing at any CCG or practice on OpenPrescribing.net.
OpenPrescribing project page update
We have updated our project page so it now gives a brief summary of each of the functions of the site: /openprescribing/ - take a look to be sure you’re making the most of all the features!
Prescribing data update!
We’ve updated OpenPrescribing with November’s data. Head over to www.openprescribing.net to see more.